These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 3286479)
1. Natural killer cell infection and inactivation in vitro by the human immunodeficiency virus. Robinson WE; Mitchell WM; Chambers WH; Schuffman SS; Montefiori DC; Oeltmann TN Hum Pathol; 1988 May; 19(5):535-40. PubMed ID: 3286479 [TBL] [Abstract][Full Text] [Related]
2. Functional analyses of natural killer cells in macaques infected with neurovirulent simian immunodeficiency virus. Shieh TM; Carter DL; Blosser RL; Mankowski JL; Zink MC; Clements JE J Neurovirol; 2001 Feb; 7(1):11-24. PubMed ID: 11519478 [TBL] [Abstract][Full Text] [Related]
3. Natural killer cell function in patients with acquired immunodeficiency syndrome and related diseases. Brenner BG; Dascal A; Margolese RG; Wainberg MA J Leukoc Biol; 1989 Jul; 46(1):75-83. PubMed ID: 2659714 [TBL] [Abstract][Full Text] [Related]
4. Interactions between natural killer cells and antibody Fc result in enhanced antibody neutralization of human immunodeficiency virus type 1. Forthal DN; Landucci G; Phan TB; Becerra J J Virol; 2005 Feb; 79(4):2042-9. PubMed ID: 15681406 [TBL] [Abstract][Full Text] [Related]
5. Cytolytic activity of natural killer cells and lymphokine activated killer cells against hepatitis A virus infected fibroblasts. Baba M; Hasegawa H; Nakayabu M; Fukai K; Suzuki S J Clin Lab Immunol; 1993; 40(2):47-60. PubMed ID: 7932628 [TBL] [Abstract][Full Text] [Related]
6. Augmentation of natural cytotoxicity by leucine enkephalin in cultured peripheral blood mononuclear cells from patients infected with human immunodeficiency virus. Oleson D; Grierson H; Goldsmith J; Purtilo DT; Johnson D Clin Immunol Immunopathol; 1989 Jun; 51(3):386-95. PubMed ID: 2721034 [TBL] [Abstract][Full Text] [Related]
7. Association of alpha interferon production with natural killer cell lysis of U937 cells infected with human immunodeficiency virus. Rappocciolo G; Toso JF; Torpey DJ; Gupta P; Rinaldo CR J Clin Microbiol; 1989 Jan; 27(1):41-8. PubMed ID: 2913035 [TBL] [Abstract][Full Text] [Related]
8. Analysis of the cytolytic activity mediated by natural killer cells from acquired immunodeficiency syndrome patients in response to phytohemagglutinin or anti-CD16 monoclonal antibody. Sirianni MC; Mezzaroma I; Aiuti F; Moretta A Eur J Immunol; 1994 Aug; 24(8):1874-8. PubMed ID: 8056046 [TBL] [Abstract][Full Text] [Related]
9. Natural killer and lymphokine-activated killer cell activities from human marrow precursors. II. The effects of IL-3 and IL-4. Keever CA; Pekle K; Gazzola MV; Collins NH; Bourhis JH; Gillio A J Immunol; 1989 Nov; 143(10):3241-9. PubMed ID: 2809200 [TBL] [Abstract][Full Text] [Related]
10. Natural killer cell-mediated lysis of T cell lines chronically infected with HIV-1. Bandyopadhyay S; Ziegner U; Campbell DE; Miller DS; Hoxie JA; Starr SE Clin Exp Immunol; 1990 Mar; 79(3):430-5. PubMed ID: 1969336 [TBL] [Abstract][Full Text] [Related]
11. Circulating CD56dim natural killer cells and CD56+ T cells that produce interferon-γ or interleukin-10 are expanded in asymptomatic, E antigen-negative patients with persistent hepatitis B virus infection. Conroy MJ; Mac Nicholas R; Grealy R; Taylor M; Otegbayo JA; O'Dea S; Mulcahy F; Ryan T; Norris S; Doherty DG J Viral Hepat; 2015 Mar; 22(3):335-45. PubMed ID: 25186004 [TBL] [Abstract][Full Text] [Related]
12. Mannoprotein-induced anti-U937 cell cytotoxicity in peripheral blood mononuclear cells from uninfected or HIV-infected subjects: role of interferon-gamma and tumor necrosis factor-alpha. Gomez MJ; Torosantucci A; Quinti I; Testa U; Peschle C; Cassone A Cell Immunol; 1993 Dec; 152(2):530-43. PubMed ID: 8258154 [TBL] [Abstract][Full Text] [Related]
14. Molecular and functional characterization of NKG2D, NKp80, and NKG2C triggering NK cell receptors in rhesus and cynomolgus macaques: monitoring of NK cell function during simian HIV infection. Biassoni R; Fogli M; Cantoni C; Costa P; Conte R; Koopman G; Cafaro A; Ensoli B; Moretta A; Moretta L; De Maria A J Immunol; 2005 May; 174(9):5695-705. PubMed ID: 15843571 [TBL] [Abstract][Full Text] [Related]
15. Human immunodeficiency virus-induced pathology favored by cellular transmission and activation. Lewis DE; Yoffe B; Bosworth CG; Hollinger FB; Rich RR FASEB J; 1988 Mar; 2(3):251-5. PubMed ID: 2965047 [TBL] [Abstract][Full Text] [Related]
16. Natural killer cytotoxicity and antibody-dependent cellular cytotoxicity of human immunodeficiency virus-infected cells by leukocytes from human neonates and adults. Jenkins M; Mills J; Kohl S Pediatr Res; 1993 May; 33(5):469-74. PubMed ID: 8511019 [TBL] [Abstract][Full Text] [Related]
17. Interleukin 15-mediated induction of cytotoxic effector cells capable of eliminating Epstein-Barr virus-transformed/immortalized lymphocytes in culture. Sharif-Askari E; Fawaz LM; Tran P; Ahmad A; Menezes J J Natl Cancer Inst; 2001 Nov; 93(22):1724-32. PubMed ID: 11717333 [TBL] [Abstract][Full Text] [Related]
18. Human mononuclear cells which produce interferon-alpha during NK(HSV-FS) assays are HLA-DR positive cells distinct from cytolytic natural killer effectors. Fitzgerald-Bocarsly P; Feldman M; Mendelsohn M; Curl S; Lopez C J Leukoc Biol; 1988 Apr; 43(4):323-34. PubMed ID: 2832497 [TBL] [Abstract][Full Text] [Related]
19. Natural and antibody-dependent cytotoxicity in different clinical stages of human immunodeficiency virus type 1 infection. Ljunggren K; Karlson A; Fenyö EM; Jondal M Clin Exp Immunol; 1989 Feb; 75(2):184-9. PubMed ID: 2649286 [TBL] [Abstract][Full Text] [Related]
20. Natural killer cells in rhesus monkeys: properties of effector cells which lyse Raji targets. Carver FM; Thomas JM Cell Immunol; 1988 Nov; 117(1):56-69. PubMed ID: 2902933 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]